LivaNova PLC (LIVN) · Insider trading

What LivaNova's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$1.05M

3 insiders, 0% under a plan

Net, 12 months

−$1.05M

bought less sold

Latest filing

2026-09-14

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $460,301

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Bianchi FrancescoDirector	–	$785,638	6	2026-09-10	4,434
Tezel AhmetChief Innovation Officer	–	$207,954	1	2026-08-11	6,090
Story BrookeDirector	–	$200,751	2	2026-09-04	7,488

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-09-10	Bianchi FrancescoDirector	Sale	3,500	78.01	$273,035	4,434	Form 4
2026-09-04	Story BrookeDirector	Sale	2,300	81.42	$187,266	7,488	Form 4
2026-08-31	Bianchi FrancescoDirector	Sale	1,650	79.72	$131,538	7,934	Form 4
2026-08-11	Tezel AhmetChief Innovation Officer	Sale	2,675	77.74	$207,954	6,090	Form 4
2026-06-15	Bianchi FrancescoDirector	Sale	1,200	80.19	$96,228	9,584	Form 4
2026-05-26	Bianchi FrancescoDirector	Sale	1,800	75.75	$136,350	7,228	Form 4
2025-11-18	Story BrookeDirector	Sale	250	53.94	$13,485	6,232	Form 4
2025-08-25	Bianchi FrancescoDirector	Sale	1,500	56.50	$84,750	9,028	Form 4
2024-12-11	Bianchi FrancescoDirector	Sale	1,250	50.99	$63,738	7,522	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

42 × shares withheld for tax41 × option exercise1 × returned to the company

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-08-11	Tezel AhmetChief Innovation Officer	Option exercise M	+12,692	52.68	18,782	Form 4
2026-08-11	Tezel AhmetChief Innovation Officer	Returned to the company D	−8,589	77.86	10,193	Form 4
2026-08-11	Tezel AhmetChief Innovation Officer	Shares withheld for tax F	−1,428	77.86	8,765	Form 4
2026-06-15	Zurbay DonaldDirector	Option exercise M	+2,560	–	2,560	Form 4
2026-06-15	Zurbay DonaldDirector	Shares withheld for tax F	−308	79.70	2,252	Form 4
2026-06-15	Story BrookeDirector	Option exercise M	+4,042	–	10,274	Form 4
2026-06-15	Story BrookeDirector	Shares withheld for tax F	−486	79.70	9,788	Form 4
2026-06-15	Enxing Seng StacyDirector	Option exercise M	+4,042	–	15,793	Form 4
2026-06-15	Enxing Seng StacyDirector	Shares withheld for tax F	−486	79.70	15,307	Form 4
2026-06-15	Kozy William ADirector	Option exercise M	+5,681	–	38,248	Form 4
2026-06-15	Kozy William ADirector	Shares withheld for tax F	−682	79.70	37,566	Form 4
2026-06-15	Tezel AhmetChief Innovation Officer	Option exercise M	+2,965	–	7,122	Form 4
2026-06-15	Tezel AhmetChief Innovation Officer	Shares withheld for tax F	−1,032	79.70	6,090	Form 4
2026-06-15	Barry James ChristopherDirector	Option exercise M	+4,042	–	8,404	Form 4
2026-06-15	Barry James ChristopherDirector	Shares withheld for tax F	−486	79.70	7,918	Form 4
2026-06-15	Podlogar Susan MDirector	Option exercise M	+4,042	–	6,128	Form 4
2026-06-15	Podlogar Susan MDirector	Shares withheld for tax F	−486	79.70	5,642	Form 4
2026-06-15	Bianchi FrancescoDirector	Option exercise M	+4,042	–	11,270	Form 4
2026-06-15	Bianchi FrancescoDirector	Shares withheld for tax F	−486	79.70	10,784	Form 4
2026-06-15	Schermerhorn Todd CDirector	Option exercise M	+4,042	–	13,105	Form 4
2026-06-15	Schermerhorn Todd CDirector	Shares withheld for tax F	−486	79.70	12,619	Form 4
2026-06-15	Wilver Peter MDirector	Option exercise M	+4,042	–	10,780	Form 4
2026-06-15	Wilver Peter MDirector	Shares withheld for tax F	−486	79.70	10,294	Form 4
2026-03-30	Kozmina NataliaChief Human Resources Officer	Option exercise M	+6,389	–	6,389	Form 4
2026-03-30	Kozmina NataliaChief Human Resources Officer	Shares withheld for tax F	−1,374	61.27	5,015	Form 4
2026-03-30	Bolton StephaniePresident, Global Epilepsy	Option exercise M	+17,815	–	30,566	Form 4
2026-03-30	Bolton StephaniePresident, Global Epilepsy	Shares withheld for tax F	−8,377	61.27	22,189	Form 4
2026-03-30	Makatsaria VladimirDirector, Chief Executive Officer	Option exercise M	+21,042	–	25,326	Form 4
2026-03-30	Makatsaria VladimirDirector, Chief Executive Officer	Shares withheld for tax F	−11,159	61.27	14,167	Form 4
2026-03-30	Shvartsburg AlexChief Financial Officer	Option exercise M	+30,835	–	57,515	Form 4
2026-03-30	Shvartsburg AlexChief Financial Officer	Shares withheld for tax F	−12,868	61.27	44,647	Form 4
2026-03-30	Poletti FrancoPresident, Cardiopulmonary	Option exercise M	+3,184	–	12,125	Form 4
2026-03-30	Poletti FrancoPresident, Cardiopulmonary	Shares withheld for tax F	−1,370	61.27	10,755	Form 4
2026-03-30	Tezel AhmetChief Innovation Officer	Option exercise M	+3,408	–	5,343	Form 4
2026-03-30	Tezel AhmetChief Innovation Officer	Shares withheld for tax F	−1,186	61.27	4,157	Form 4
2026-03-11	Poletti FrancoPresident, Cardiopulmonary	Option exercise M	+2,140	57.60	10,990	Form 4
2026-03-11	Poletti FrancoPresident, Cardiopulmonary	Shares withheld for tax F	−1,980	62.26	9,010	Form 4
2026-03-11	Poletti FrancoPresident, Cardiopulmonary	Shares withheld for tax F	−69	62.26	8,941	Form 4
2025-12-15	Hutchinson Michael DamonSVP, CLO and Company Secretary	Option exercise M	+2,254	–	7,920	Form 4
2025-12-15	Hutchinson Michael DamonSVP, CLO and Company Secretary	Shares withheld for tax F	−1,122	63.06	6,798	Form 4
2025-12-15	Podlogar Susan MDirector	Option exercise M	+2,355	–	2,355	Form 4
2025-12-15	Podlogar Susan MDirector	Shares withheld for tax F	−269	63.06	2,086	Form 4
2025-12-15	Poletti FrancoPresident, Cardiopulmonary	Option exercise M	+967	–	9,266	Form 4
2025-12-15	Poletti FrancoPresident, Cardiopulmonary	Shares withheld for tax F	−416	63.06	8,850	Form 4
2025-09-15	Poletti FrancoPresident, Cardiopulmonary	Option exercise M	+643	–	8,576	Form 4
2025-09-15	Poletti FrancoPresident, Cardiopulmonary	Shares withheld for tax F	−277	55.43	8,299	Form 4
2025-06-15	Tezel AhmetChief Innovation Officer	Option exercise M	+2,967	–	2,967	Form 4
2025-06-15	Tezel AhmetChief Innovation Officer	Shares withheld for tax F	−1,032	45.76	1,935	Form 4
2025-06-15	Wilver Peter MDirector	Option exercise M	+3,416	–	7,148	Form 4
2025-06-15	Wilver Peter MDirector	Shares withheld for tax F	−410	45.76	6,738	Form 4
2025-06-15	Enxing Seng StacyDirector	Option exercise M	+3,416	–	12,161	Form 4
2025-06-15	Enxing Seng StacyDirector	Shares withheld for tax F	−410	45.76	11,751	Form 4
2025-06-15	Story BrookeDirector	Option exercise M	+3,416	–	6,892	Form 4
2025-06-15	Story BrookeDirector	Shares withheld for tax F	−410	45.76	6,482	Form 4
2025-06-15	Barry James ChristopherDirector	Option exercise M	+3,416	–	4,772	Form 4
2025-06-15	Barry James ChristopherDirector	Shares withheld for tax F	−410	45.76	4,362	Form 4
2025-06-15	Kozy William ADirector	Option exercise M	+4,840	–	33,148	Form 4
2025-06-15	Kozy William ADirector	Shares withheld for tax F	−581	45.76	32,567	Form 4
2025-06-15	Schermerhorn Todd CDirector	Option exercise M	+3,416	–	9,473	Form 4
2025-06-15	Schermerhorn Todd CDirector	Shares withheld for tax F	−410	45.76	9,063	Form 4
2025-06-15	Bianchi FrancescoDirector	Option exercise M	+3,416	–	10,938	Form 4
2025-06-15	Bianchi FrancescoDirector	Shares withheld for tax F	−410	45.76	10,528	Form 4
2025-06-15	O'Kane SharonDirector	Option exercise M	+3,416	–	12,910	Form 4
2025-06-15	O'Kane SharonDirector	Shares withheld for tax F	−1,606	45.76	11,304	Form 4
2025-03-30	Poletti FrancoPresident, Cardiopulmonary	Option exercise M	+1,257	–	8,475	Form 4
2025-03-30	Poletti FrancoPresident, Cardiopulmonary	Shares withheld for tax F	−542	39.13	7,933	Form 4
2025-03-30	Shvartsburg AlexChief Financial Officer	Option exercise M	+11,083	–	30,196	Form 4
2025-03-30	Shvartsburg AlexChief Financial Officer	Shares withheld for tax F	−3,516	39.13	26,680	Form 4
2025-03-30	Hutchinson Michael DamonChief Legal Officer	Option exercise M	+2,930	–	6,686	Form 4
2025-03-30	Hutchinson Michael DamonChief Legal Officer	Shares withheld for tax F	−1,020	39.13	5,666	Form 4
2025-03-30	Kozy William ADirector	Option exercise M	+1,034	–	28,496	Form 4
2025-03-30	Kozy William ADirector	Shares withheld for tax F	−188	39.13	28,308	Form 4
2025-03-30	Makatsaria VladimirDirector, Chief Executive Officer	Option exercise M	+9,330	–	9,330	Form 4
2025-03-30	Makatsaria VladimirDirector, Chief Executive Officer	Shares withheld for tax F	−5,046	39.13	4,284	Form 4
2025-03-30	Bolton StephaniePresident, Global Epilepsy	Option exercise M	+6,024	–	15,586	Form 4
2025-03-30	Bolton StephaniePresident, Global Epilepsy	Shares withheld for tax F	−2,835	39.13	12,751	Form 4
2024-12-15	Shvartsburg AlexChief Financial Officer	Option exercise M	+613	–	19,342	Form 4
2024-12-15	Shvartsburg AlexChief Financial Officer	Shares withheld for tax F	−229	51.50	19,113	Form 4
2024-12-15	Barry James ChristopherDirector	Option exercise M	+1,709	–	1,709	Form 4
2024-12-15	Barry James ChristopherDirector	Shares withheld for tax F	−353	51.50	1,356	Form 4
2024-12-15	Poletti FrancoPresident, Cardiopulmonary	Option exercise M	+967	–	7,634	Form 4
2024-12-15	Poletti FrancoPresident, Cardiopulmonary	Shares withheld for tax F	−416	51.50	7,218	Form 4
2024-12-15	Hutchinson Michael DamonChief Legal Officer	Option exercise M	+2,254	–	4,540	Form 4
2024-12-15	Hutchinson Michael DamonChief Legal Officer	Shares withheld for tax F	−784	51.50	3,756	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

LivaNova's scores and multiples ›